Maccabi Health care Services implements Seegnal Point of Care on a national scale

Maccabi Health care Services announces the implementation of Seegnal Point of Care on a national scale: "Setting the standards in Israel for personalized medication and safe practicing."

• Integrated into the EMR Medicine Prescription workflow, Seegnal ensures that possible Adverse Drug Effects stemming from multiple medications prescribed, a mismatch between medication and personal attributes, or a mismatch with recent lab and medical conditions are captured during the prescription phase, thus safeguarding patients from possible severe side effects and harm.
• Almost 22 million prescriptions and 175 million medications are analyzed per year, eliminating over 1.3 million prescriptions that can possibly cause Drug Related Problems in real-time.
• Fast and reliable – With response times under 180 milliseconds, and 24x7 availability, Seegnal Point of Care proves to be scalable and reliable.

Tel Aviv, Israel; April 23, 2023: Following the completion of the national deployment of Seegnal latest product offering across Israel, Maccabi Health care Services began applying cutting-edge technology to minimize drug prescription errors. Seegnal is integrated as part of the medication prescription workflow at the point of care, analyzing over 175 million prescriptions annually to detect possible drug side effects resulting from contradicting medicine or mismatch between medication prescribed to the latest lab results and personal medical condition. With an average of 6% of the prescription being flagged as potentially having medication misalignments, Maccabi Healthcare Services is flagging over 1.3M prescriptions yearly as potentially harmful, safeguarding its patients and ensuring the best medicine therapy is conducted. Seegnal’s cloud-based technology calculates hundreds of parameters in real-time during the patient visit in just under 180 milliseconds to present the doctors with a comprehensive medicine overview of the patient 24X7.

Maccabi is one of the largest HMOs in the world, with 2.6 million members and about 100,000 medical interactions per day.

Maccabi's Chief Physician, Daniel Landsberger, M.D: "This is significant news in the field of safe medical practice. We are proud to be the first health organization to provide this service widely. In the future, we believe that this type of technology will become a central and leading tool in the process of administrating medications."

Director of Medical Informatics (Digital Health) at Maccabi, Shira Greenfeld M.D, said: "The Seegnal DRP solution packs intelligence, usability, and personalized medical treatment, delivering capabilities and benefits unseen before. Seegnal’s ability to incorporate hundreds of patient-specific parameters and immediately present patient-tailored DRP alerts is unique. The user-friendly graphic interface is adjustable to suit the clinician’s preference. Patient-specific medicine should be an integral part of patient care, and Maccabi is leading the standards in Israel for personalized medication and safe practice”.

Eyal Schneid, CEO of Seegnal: "We are delighted to collaborate with Maccabi and for the opportunity to provide innovative, safe medical solutions to its members. We are looking forward to enhancing the partnership as we introduce new functionality. This project is another testimony to MHS leadership in innovation and that it puts its members' health at the center of its activities.

 About Maccabi

Maccabi Healthcare Services is one of the world's largest public healthcare providers, with 2.6 million members. Maccabi has long been recognized, both in Israel and abroad, as a unique and innovative healthcare system that leads the way in cutting-edge medical technology, comprehensive and integrated computerized information systems, cost–effective management, and sophisticated monitoring and evaluation tools.

 About Seegnal

Seegnal is the world leader in providing precision medication decision support software to doctors at the point of care and pharmacists at the point of distribution. With an unparalleled accuracy alerting for possible adverse drug effects, considering hundreds of patient-specific parameters, Seegnal not only eradicates severe medicine interactions but also allows for precise medication therapy (including pharmacogenomics), improving the lives of millions of patients daily.